Bunney W E
Psychopharmacol Commun. 1975;1(6):599-609.
The catecholamine theory suggests that there is a functional deficit of the catecholamine neurotransmitter, norepinephrine (NE) or dopamine (DA) at the neuronal synaptic cleft in depression and an excess in mania. Current strategies which are being utilized to investigate this theory involve: 1)studies of DA, NE, their breakdown products and synthetic and degradative enzymes in body fluids and brain tissue; 2) studies of modes of action of drug which can "activate" or decrease manic or depressive symptoms; 3) the study of pharmacological agents which affect specific aspects of NE and DA metabolism, (synthesis, release, receptor sensitivity, and degradation). The total accumlated data seems more compatible with a catecholamine hypothesis of mania than one of depression. The evidence to date does not allow one to differentiate between the importance of DA or NE either in depression of mania.
儿茶酚胺理论认为,在抑郁症中,儿茶酚胺神经递质去甲肾上腺素(NE)或多巴胺(DA)在神经元突触间隙存在功能缺陷,而在躁狂症中则过量。目前用于研究该理论的策略包括:1)研究体液和脑组织中的DA、NE、它们的分解产物以及合成和降解酶;2)研究可“激活”或减轻躁狂或抑郁症状的药物的作用模式;3)研究影响NE和DA代谢特定方面(合成、释放、受体敏感性和降解)的药物制剂。迄今为止积累的全部数据似乎更符合躁狂症的儿茶酚胺假说,而非抑郁症的假说。目前的证据无法让人区分DA或NE在抑郁症或躁狂症中的重要性。